Tamara Pérez-Jeldres Selected Research

4-deoxypyridoxine

1/2020

Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tamara Pérez-Jeldres Research Topics

Disease

3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 04/2016
2	Multiple Sclerosis 08/2021 - 06/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2021 - 04/2016
1	COVID-19 06/2021
1	Anemia 06/2021
1	Infections 06/2021
1	Inflammation (Inflammations) 06/2021
1	Leukopenia 06/2021
1	Macular Edema 06/2021
1	Ileitis 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Ulcerative Colitis 01/2019

Drug/Important Bio-Agent (IBA)

2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 08/2021 - 06/2021
2	CytokinesIBA 01/2020 - 01/2019
1	ozanimodIBA 06/2021
1	etrasimodIBA 06/2021
1	ponesimodIBA 06/2021
1	siponimodIBA 06/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 06/2021
1	Transaminases (Aminotransferases)IBA 06/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2021
1	sphingosine 1-phosphate lyase (aldolase)IBA 01/2020
1	LyasesIBA 01/2020
1	4-deoxypyridoxineIBA 01/2020
1	imidazoleIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2019
1	tofacitinibIBA 01/2019
1	Pharmaceutical PreparationsIBA 04/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016

Therapy/Procedure

2	Therapeutics 10/2018 - 04/2016
1	Oral Administration 01/2020